A detailed history of Boyar Asset Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boyar Asset Management Inc. holds 30,067 shares of BMY stock, worth $1.72 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
30,067
Previous 30,065 0.01%
Holding current value
$1.72 Million
Previous $1.25 Million 24.6%
% of portfolio
1.04%
Previous 0.89%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 22, 2024

BUY
$39.66 - $51.75 $79 - $103
2 Added 0.01%
30,067 $1.56 Million
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $14,127 - $18,599
-351 Reduced 1.15%
30,065 $1.25 Million
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $62,805 - $71,209
1,309 Added 4.5%
30,416 $1.65 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $102,195 - $121,947
-2,108 Reduced 6.75%
29,107 $1.49 Million
Q3 2023

Nov 07, 2023

SELL
$57.89 - $64.73 $20,261 - $22,655
-350 Reduced 1.11%
31,215 $1.81 Million
Q2 2023

Jul 26, 2023

SELL
$63.71 - $70.74 $8,473 - $9,408
-133 Reduced 0.42%
31,565 $2.02 Million
Q1 2023

Apr 27, 2023

BUY
$65.71 - $74.53 $24,378 - $27,650
371 Added 1.18%
31,698 $2.2 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $27,323 - $32,354
-399 Reduced 1.26%
31,327 $2.25 Million
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $6 - $3,765
-49 Reduced 0.15%
31,726 $2.26 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $227,010 - $250,017
-3,126 Reduced 8.96%
31,775 $2.45 Million
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $13,279 - $15,923
216 Added 0.62%
34,901 $2.55 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $5,363 - $6,252
-100 Reduced 0.29%
34,685 $2.16 Million
Q3 2021

Oct 18, 2021

SELL
$59.17 - $69.31 $4,911 - $5,752
-83 Reduced 0.24%
34,785 $2.06 Million
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $61 - $67
1 Added 0.0%
34,868 $2.33 Million
Q1 2021

May 04, 2021

SELL
$59.34 - $66.74 $17,980 - $20,222
-303 Reduced 0.86%
34,867 $2.2 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $159,882 - $181,175
-2,769 Reduced 7.3%
35,170 $2.18 Million
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $41,062 - $45,502
715 Added 1.92%
37,939 $2.29 Million
Q1 2020

Apr 17, 2020

SELL
$46.4 - $67.43 $23,153 - $33,647
-499 Reduced 1.32%
37,224 $2.08 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $34,791 - $45,382
-707 Reduced 1.84%
37,723 $2.42 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $29,939 - $35,497
-700 Reduced 1.79%
38,430 $1.95 Million
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $13,519 - $14,950
-303 Reduced 0.77%
39,130 $1.78 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $35,838 - $46,474
-735 Reduced 1.83%
39,433 $2.05 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $14,800 - $17,038
-247 Reduced 0.61%
40,168 $2.54 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $9,470 - $10,325
158 Added 0.39%
40,415 $2.48 Million
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $2.22 Million - $2.57 Million
40,257
40,257 $2.57 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Boyar Asset Management Inc. Portfolio

Follow Boyar Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyar Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boyar Asset Management Inc. with notifications on news.